Home » Prices » NASDAQ:CRNX

Crinetics Pharmaceuticals, Inc. stock price

Today's NASDAQ:CRNX chart, history & news

Price:
14.36 USD
Change:
+1.29 (9.87%)
Key Stats
Price open 13.1
Previous close 13.07
Market cap 472.76M
Volume 71.49K
Day high 14.61
Day low 13.1
Year high 26.46
Year low 11.52
Year to date change -33.59%
P/E Ratio N.A
Company Profile
Fundamentals
Insider Information
News

About Crinetics Pharmaceuticals, Inc.

Crinetics Pharmaceuticals, Inc. operates as a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its product candidate, CRN00808, is an oral nonpeptide somatostatin agonist for the treatment of acromegaly. The firm is also developing other oral nonpeptide somatostatin agonists for neuroendocrine tumors and hyperinsulinism, as well as an oral nonpeptide ACTH antagonist for the treatment of Cushing's disease. The company was founded by R. Scott Struthers, Yun-Fei Zhu and Stephen F. Betz in 2008 and is headquartered in San Diego, CA.

Company information

Company name
Crinetics Pharmaceuticals Inc
Exchange
Sector
Health Technology
Industry
Pharmaceuticals: Major
Employees
68
CEO
Scott R. Struthers
Address
10222 Barnes Canyon Road, San Diego, CA, 92121
Country
United States
Contact information
1.858.450.6464
Website
http://www.crinetics.com

Related companies

Invezz uses cookies to provide you with a great user experience. By using Invezz, you accept our privacy policy.